Phase 2a MIB-626 vs. Placebo COVID-19

Clinical trial NCT05038488 · COMPLETED

Trial details

NCT number: NCT05038488
Sponsor: Metro International Biotech, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Covid19 Stage 1 Acute Kidney Injury

Start date: 2021-10-26
Primary completion: 2023-08-17
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.